# Fluent, Inc.: financial statements, quarterly

FLNT · Nasdaq · CIK 1460329 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/flnt.md) · [Financials](/companies/flnt/financials.md) · [Filings](/companies/flnt/filings.md) · [Insiders](/companies/flnt/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/flnt/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [66.2](/filings/0001437749-24-035493.md) | [72.8 d](/filings/0001437749-25-010194.md) | [66.0](/filings/0001437749-25-017449.md) | [58.7](/filings/0001437749-25-027383.md) | [64.5](/filings/0001437749-25-035012.md) | [65.4 d](/filings/0001437749-26-010679.md) | [55.2](/filings/0001437749-26-016747.md) | [44.7](/filings/0001437749-26-027702.md) | [47.0](/filings/0001437749-25-035012.md) | [61.8 d](/filings/0001437749-26-010679.md) | [44.9](/filings/0001437749-26-016747.md) | [48.4](/filings/0001437749-26-027702.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross profit | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Research and development | $m | [4.5](/filings/0001437749-24-035493.md) | [4.4 d](/filings/0001437749-25-010194.md) | [4.8](/filings/0001437749-25-017449.md) | [4.7](/filings/0001437749-25-027383.md) | [4.1](/filings/0001437749-25-035012.md) | [3.6 d](/filings/0001437749-26-010679.md) | [3.4](/filings/0001437749-26-016747.md) | [2.3](/filings/0001437749-26-027702.md) | [2.6](/filings/0001437749-25-035012.md) | [2.9 d](/filings/0001437749-26-010679.md) | [2.8](/filings/0001437749-26-016747.md) | [3.0](/filings/0001437749-26-027702.md) |
| Operating income | $m | [(33.9)](/filings/0001437749-24-035493.md) | [(1.8) d](/filings/0001437749-25-010194.md) | [(4.0)](/filings/0001437749-25-017449.md) | [(10.4)](/filings/0001437749-25-027383.md) | [(3.9)](/filings/0001437749-25-035012.md) | [(5.4) d](/filings/0001437749-26-010679.md) | [(7.1)](/filings/0001437749-26-016747.md) | [(7.1)](/filings/0001437749-26-027702.md) | [(6.3)](/filings/0001437749-25-035012.md) | [0.2 d](/filings/0001437749-26-010679.md) | [(3.9)](/filings/0001437749-26-016747.md) | [(5.0)](/filings/0001437749-26-027702.md) |
| Interest expense | $m | [0.9](/filings/0001437749-24-035493.md) | [0.8 d](/filings/0001437749-24-010639.md) | [1.4](/filings/0001437749-25-017449.md) | [1.0](/filings/0001437749-25-027383.md) | [1.3](/filings/0001437749-25-035012.md) | [1.0 d](/filings/0001437749-26-010679.md) | [0.9](/filings/0001437749-26-016747.md) | [0.7](/filings/0001437749-26-027702.md) | [0.7](/filings/0001437749-25-035012.md) | [0.8 d](/filings/0001437749-26-010679.md) | [0.6](/filings/0001437749-26-016747.md) | [0.6](/filings/0001437749-26-027702.md) |
| Income tax | $m | [(1.2)](/filings/0001437749-24-035493.md) | [(0.7) d](/filings/0001437749-25-010194.md) | [0.9](/filings/0001437749-25-017449.md) | [(0.8)](/filings/0001437749-25-027383.md) | [(0.0)](/filings/0001437749-25-035012.md) | [(1.9) d](/filings/0001437749-26-010679.md) | [0.2](/filings/0001437749-26-016747.md) | [(0.1)](/filings/0001437749-26-027702.md) | [(0.0)](/filings/0001437749-25-035012.md) | [(0.1) d](/filings/0001437749-26-010679.md) | [0.0](/filings/0001437749-26-016747.md) | [0.0](/filings/0001437749-26-027702.md) |
| Net income | $m | [(33.6)](/filings/0001437749-24-035493.md) | [(1.9) d](/filings/0001437749-25-010194.md) | [(6.3)](/filings/0001437749-25-017449.md) | [(11.6)](/filings/0001437749-25-027383.md) | [(7.9)](/filings/0001437749-25-035012.md) | [(3.4) d](/filings/0001437749-26-010679.md) | [(8.3)](/filings/0001437749-26-016747.md) | [(7.2)](/filings/0001437749-26-027702.md) | [(7.6)](/filings/0001437749-25-035012.md) | [(4.1) d](/filings/0001437749-26-010679.md) | [(5.4)](/filings/0001437749-26-016747.md) | [(6.2)](/filings/0001437749-26-027702.md) |
| Diluted EPS | $ per share | [(2.43)](/filings/0001437749-24-035493.md) | not reported | [(0.45)](/filings/0001437749-25-017449.md) | [(0.75)](/filings/0001437749-25-027383.md) | [(0.48)](/filings/0001437749-25-035012.md) | not reported | [(0.39)](/filings/0001437749-26-016747.md) | [(0.30)](/filings/0001437749-26-027702.md) | [(0.27)](/filings/0001437749-25-035012.md) | not reported | [(0.17)](/filings/0001437749-26-016747.md) | [(0.20)](/filings/0001437749-26-027702.md) |
| Basic EPS | $ per share | [(2.43)](/filings/0001437749-24-035493.md) | not reported | [(0.45)](/filings/0001437749-25-017449.md) | [(0.75)](/filings/0001437749-25-027383.md) | [(0.48)](/filings/0001437749-25-035012.md) | not reported | [(0.39)](/filings/0001437749-26-016747.md) | [(0.30)](/filings/0001437749-26-027702.md) | [(0.27)](/filings/0001437749-25-035012.md) | not reported | [(0.17)](/filings/0001437749-26-016747.md) | [(0.20)](/filings/0001437749-26-027702.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: not reported
- Gross profit: not reported
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [20.5](/filings/0001437749-23-032186.md) | [15.8](/filings/0001437749-25-010194.md) | [11.7](/filings/0001437749-24-017112.md) | [5.0](/filings/0001437749-24-027236.md) | [6.6](/filings/0001437749-24-035493.md) | [9.4](/filings/0001437749-26-010679.md) | [4.8](/filings/0001437749-25-017449.md) | [4.9](/filings/0001437749-25-027383.md) | [9.2](/filings/0001437749-25-035012.md) | [12.9](/filings/0001437749-26-027702.md) | [10.3](/filings/0001437749-26-016747.md) | [6.9](/filings/0001437749-26-027702.md) |
| Current assets | $m | [77.1](/filings/0001437749-23-032186.md) | [78.4](/filings/0001437749-25-010194.md) | [71.4](/filings/0001437749-24-017112.md) | [67.1](/filings/0001437749-24-027236.md) | [66.3](/filings/0001437749-24-035493.md) | [66.0](/filings/0001437749-26-010679.md) | [51.2](/filings/0001437749-25-017449.md) | [46.9](/filings/0001437749-25-027383.md) | [49.5](/filings/0001437749-25-035012.md) | [67.5](/filings/0001437749-26-027702.md) | [49.4](/filings/0001437749-26-016747.md) | [52.6](/filings/0001437749-26-027702.md) |
| Total assets | $m | [112](/filings/0001437749-23-032186.md) | [93.6](/filings/0001437749-25-017449.md) | [104](/filings/0001437749-24-017112.md) | [98.5](/filings/0001437749-24-027236.md) | [77.5](/filings/0001437749-25-017449.md) | [93.6](/filings/0001437749-26-010679.md) | [77.5](/filings/0001437749-25-017449.md) | [74.5](/filings/0001437749-25-027383.md) | [76.1](/filings/0001437749-25-035012.md) | [89.1](/filings/0001437749-26-027702.md) | [72.3](/filings/0001437749-26-016747.md) | [75.1](/filings/0001437749-26-027702.md) |
| Current liabilities | $m | [72.2](/filings/0001437749-23-032186.md) | [49.2](/filings/0001437749-25-010194.md) | [73.5](/filings/0001437749-24-017112.md) | [69.5](/filings/0001437749-24-027236.md) | [70.4](/filings/0001437749-24-035493.md) | [64.7](/filings/0001437749-26-010679.md) | [51.7](/filings/0001437749-25-017449.md) | [49.7](/filings/0001437749-25-027383.md) | [48.4](/filings/0001437749-25-035012.md) | [65.0](/filings/0001437749-26-027702.md) | [52.2](/filings/0001437749-26-016747.md) | [59.7](/filings/0001437749-26-027702.md) |
| Total liabilities | $m | [76.6](/filings/0001437749-23-032186.md) | [77.5](/filings/0001437749-25-010194.md) | [74.8](/filings/0001437749-24-017112.md) | [71.0](/filings/0001437749-24-027236.md) | [76.0](/filings/0001437749-24-035493.md) | [68.7](/filings/0001437749-26-010679.md) | [55.5](/filings/0001437749-25-017449.md) | [55.3](/filings/0001437749-25-027383.md) | [54.5](/filings/0001437749-25-035012.md) | [70.9](/filings/0001437749-26-027702.md) | [59.0](/filings/0001437749-26-016747.md) | [67.0](/filings/0001437749-26-027702.md) |
| Long-term debt | $m | [0.0](/filings/0001437749-23-032186.md) | [25.5](/filings/0001437749-25-010194.md) | [0.0](/filings/0001437749-24-017112.md) | [0.8](/filings/0001437749-24-027236.md) | [5.4](/filings/0001437749-24-035493.md) | [4.0](/filings/0001437749-26-010679.md) | [3.8](/filings/0001437749-25-017449.md) | [3.3](/filings/0001437749-25-027383.md) | [3.9](/filings/0001437749-25-035012.md) | [3.7](/filings/0001437749-26-027702.md) | [4.6](/filings/0001437749-26-016747.md) | [5.2](/filings/0001437749-26-027702.md) |
| Current portion of debt | $m | [31.8](/filings/0001437749-23-032186.md) | [5.0](/filings/0001437749-25-010194.md) | [31.0](/filings/0001437749-24-017112.md) | [32.5](/filings/0001437749-24-027236.md) | [32.6](/filings/0001437749-24-035493.md) | [31.6](/filings/0001437749-26-010679.md) | [21.8](/filings/0001437749-25-017449.md) | [19.9](/filings/0001437749-25-027383.md) | [22.2](/filings/0001437749-25-035012.md) | [30.8](/filings/0001437749-26-027702.md) | [23.5](/filings/0001437749-26-016747.md) | [26.8](/filings/0001437749-26-027702.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [35.5](/filings/0001437749-24-035493.md) | [34.4](/filings/0001437749-26-010679.md) | [28.7](/filings/0001437749-25-027383.md) | [27.5](/filings/0001437749-25-035012.md) | [20.0](/filings/0001437749-25-035012.md) | [25.0](/filings/0001437749-26-027702.md) | [22.0](/filings/0001437749-26-027702.md) | [19.1](/filings/0001437749-26-027702.md) | [21.6](/filings/0001437749-25-035012.md) | [18.2](/filings/0001437749-26-027702.md) | [13.3](/filings/0001437749-26-027702.md) | [8.1](/filings/0001437749-26-027702.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [7.6 d](/filings/0001437749-24-035493.md) | [(1.6) d](/filings/0001437749-25-010194.md) | [(0.1)](/filings/0001437749-25-017449.md) | [(13.1) d](/filings/0001437749-25-027383.md) | [1.2 d](/filings/0001437749-25-035012.md) | [(2.1) d](/filings/0001437749-26-010679.md) | [2.1](/filings/0001437749-26-016747.md) | [0.9 d](/filings/0001437749-26-027702.md) | [(7.3) d](/filings/0001437749-25-035012.md) | [2.8 d](/filings/0001437749-26-010679.md) | [5.1](/filings/0001437749-26-016747.md) | [(4.8) d](/filings/0001437749-26-027702.md) |
| Capital expenditure | $m | [0.0 d](/filings/0001437749-24-035493.md) | [0.0 d](/filings/0001437749-25-010194.md) | not reported | not reported | [0.0 d](/filings/0001437749-25-035012.md) | [0.0 d](/filings/0001437749-26-010679.md) | [0.0](/filings/0001437749-26-016747.md) | [0.0 d](/filings/0001437749-26-027702.md) | [0.0 d](/filings/0001437749-25-035012.md) | [0.0 d](/filings/0001437749-26-010679.md) | [0.1](/filings/0001437749-26-016747.md) | [0.0 d](/filings/0001437749-26-027702.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [81.7](/filings/0001437749-23-032186.md) | [13.7](/filings/0001437749-24-017112.md) | [13.8](/filings/0001437749-24-027236.md) | [13.8](/filings/0001437749-24-035493.md) | [13.9](/filings/0001437749-25-017449.md) | [15.5](/filings/0001437749-25-027383.md) | [16.5](/filings/0001437749-25-035012.md) | [21.2](/filings/0001437749-26-016747.md) | [24.1](/filings/0001437749-26-027702.md) | [28.1](/filings/0001437749-25-035012.md) | [31.3](/filings/0001437749-26-016747.md) | [31.5](/filings/0001437749-26-027702.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 31,607,086 at 2026-08-10, from the cover of the [10-Q filed 2026-08-13](/filings/0001437749-26-027702.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:40 ET. No prices; not investment advice.